No Data
Press Release: Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 10th, 2024
Teva Pharmaceutical Industries Options Spot-On: On November 27th, 63,244 Contracts Were Traded, With 622.89K Open Interest
Unusual Options Activity: AAL, COIN and Others Attract Market Bets, AAL V/OI Ratio Reaches 75.0
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More